Adverse events192

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 192

Type	Event	Organ system	Group	Affected	At risk
other	Nausea	Gastrointestinal disorders	Pegylated Liposomal Doxorubicin + SL-172154	11	21
other	Nausea	Gastrointestinal disorders	Mirvetuximab + SL-172154	32	65
other	Constipation	Gastrointestinal disorders	Pegylated Liposomal Doxorubicin + SL-172154	9	21
other	Constipation	Gastrointestinal disorders	Mirvetuximab + SL-172154	18	65
other	Abdominal pain	Gastrointestinal disorders	Pegylated Liposomal Doxorubicin + SL-172154	6	21
other	Abdominal pain	Gastrointestinal disorders	Mirvetuximab + SL-172154	17	65
other	Diarrhoea	Gastrointestinal disorders	Pegylated Liposomal Doxorubicin + SL-172154	4	21
other	Diarrhoea	Gastrointestinal disorders	Mirvetuximab + SL-172154	30	65
other	Stomatitis	Gastrointestinal disorders	Pegylated Liposomal Doxorubicin + SL-172154	6	21
other	Stomatitis	Gastrointestinal disorders	Mirvetuximab + SL-172154	4	65
other	vomiting	Gastrointestinal disorders	Pegylated Liposomal Doxorubicin + SL-172154	4	21
other	vomiting	Gastrointestinal disorders	Mirvetuximab + SL-172154	16	65
other	Abdominal distension	Gastrointestinal disorders	Pegylated Liposomal Doxorubicin + SL-172154	3	21
other	Abdominal distension	Gastrointestinal disorders	Mirvetuximab + SL-172154	6	65
other	Gastrooesophageal reflux disease	Gastrointestinal disorders	Pegylated Liposomal Doxorubicin + SL-172154	3	21
other	Gastrooesophageal reflux disease	Gastrointestinal disorders	Mirvetuximab + SL-172154	3	65
other	Dysphagia	Gastrointestinal disorders	Pegylated Liposomal Doxorubicin + SL-172154	2	21
other	Dysphagia	Gastrointestinal disorders	Mirvetuximab + SL-172154	0	65
other	Abdominal pain upper	Gastrointestinal disorders	Pegylated Liposomal Doxorubicin + SL-172154	0	21
other	Abdominal pain upper	Gastrointestinal disorders	Mirvetuximab + SL-172154	5	65

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05483933/events

API reference For AI assistants

Adverse events192

Sources 3

Read this list from software.